首页> 外国专利> ORAL DOSAGE FORM OF BOTH CLOMIPHENE ISOMERS AND METHOD OF USING SAME TO TREAT SECONDARY HYPOGONADISM.

ORAL DOSAGE FORM OF BOTH CLOMIPHENE ISOMERS AND METHOD OF USING SAME TO TREAT SECONDARY HYPOGONADISM.

机译:克罗米酚同分异构体的口服剂量形式以及使用该药物治疗继发性低血糖症的方法。

摘要

The present invention relates to a pharmaceutical oral dosage form comprising both (A) trans-clomiphene or a pharmaceutically acceptable salt thereof and (B) cis-clomiphene or a pharmaceutically acceptable salt thereof, wherein (i) the ratio of (A):(B) in the dosage form is about 70:30; (ii) the amount of (A) in the dosage form is about 12.5 mg or about 25 mg; and (iii) the amount of (B) in the dosage form is less than 15 mg. The pharmaceutical oral dosage form is useful to treat secondary hypogonadism in men and minimize certain antiestrogenic drug side effects such as impaired cognition, hot flashes and bone loss, osteoporosis, and skeletal fractures.
机译:本发明涉及包含(A)反式克罗米芬或其药学上可接受的盐和(B)顺式克罗米芬或其药学上可接受的盐的药物口服剂型,其中(i)(A):( B)剂型中约70:30; (ii)剂型中(A)的量为约12.5mg或约25mg; (iii)剂型中(B)的量少于15毫克。口服药物剂型可用于治疗男性继发性性腺功能减退,并最大程度地减少某些抗雌激素药物副作用,例如认知障碍,潮热和骨质流失,骨质疏松和骨骼骨折。

著录项

  • 公开/公告号MX2018010286A

    专利类型

  • 公开/公告日2018-09-27

    原文格式PDF

  • 申请/专利权人 ASPEN PARK PHARMACEUTICALS INC.;

    申请/专利号MX20180010286

  • 发明设计人 HARRY FISCH;MITCHELL STEINER;

    申请日2017-02-23

  • 分类号A61K31/138;A61K31/225;

  • 国家 MX

  • 入库时间 2022-08-21 12:51:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号